共 50 条
- [1] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (10): : 1288 - 1289
- [2] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (09): : 1124 - 1125
- [3] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (04): : 450 - 451
- [4] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - THERAFECTIN - ROLE OF ARTHRITIS ADVISORY-COMMITTEE IN FDA REVIEW PROCESS - PERSONNEL CHANGES - ISSUES OF OVER-THE-COUNTER SWITCHING [J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (09): : 1408 - 1409
- [5] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - EXPANDED ROLE FOR COMMITTEE MEMBERS - GUIDELINES ON ANALGESICS [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (12): : 1619 - 1619
- [6] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - POSTMARKETING SURVEILLANCE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (10): : 1168 - 1169
- [7] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - ANALGESICS GUIDELINES - TOPICAL NSAIDS - EXTRACORPOREAL PHOTOCHEMOTHERAPY IN SCLERODERMA [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (07): : 931 - 932
- [8] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - CHANGES IN THE REVIEW PROCESS FOR ANTIARTHRITIS DRUGS - LABELING OF ANALGESICS [J]. ARTHRITIS AND RHEUMATISM, 1989, 32 (10): : 1328 - 1329
- [10] SELECTION OF FDA ADVISORY-COMMITTEE MEMBERS [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (10): : 1614 - 1614